ATE324881T1 - Antagonisten der defektiven magnesiumbindung als therapeutische mittel und methoden zur behandlung von abnormalen physiologischen zuständen - Google Patents
Antagonisten der defektiven magnesiumbindung als therapeutische mittel und methoden zur behandlung von abnormalen physiologischen zuständenInfo
- Publication number
- ATE324881T1 ATE324881T1 AT01961984T AT01961984T ATE324881T1 AT E324881 T1 ATE324881 T1 AT E324881T1 AT 01961984 T AT01961984 T AT 01961984T AT 01961984 T AT01961984 T AT 01961984T AT E324881 T1 ATE324881 T1 AT E324881T1
- Authority
- AT
- Austria
- Prior art keywords
- disubstituted
- methods
- trans
- antagonists
- therapeutic agents
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229910052749 magnesium Inorganic materials 0.000 title abstract 2
- 239000011777 magnesium Substances 0.000 title abstract 2
- 230000002159 abnormal effect Effects 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 230000002950 deficient Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000004962 physiological condition Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- -1 1,2-disubstituted trans ethylenes Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical class C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 abstract 1
- 208000007530 Essential hypertension Diseases 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical class CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/321—Arterial hypertension
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/635,266 US6455734B1 (en) | 2000-08-09 | 2000-08-09 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE324881T1 true ATE324881T1 (de) | 2006-06-15 |
Family
ID=24547100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01961984T ATE324881T1 (de) | 2000-08-09 | 2001-08-09 | Antagonisten der defektiven magnesiumbindung als therapeutische mittel und methoden zur behandlung von abnormalen physiologischen zuständen |
Country Status (9)
| Country | Link |
|---|---|
| US (12) | US6455734B1 (de) |
| EP (1) | EP1355638B1 (de) |
| JP (1) | JP2004508299A (de) |
| AT (1) | ATE324881T1 (de) |
| AU (1) | AU2001283203A1 (de) |
| CA (1) | CA2418951A1 (de) |
| DE (1) | DE60119385D1 (de) |
| NZ (1) | NZ523915A (de) |
| WO (1) | WO2002011714A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372440B2 (en) * | 1999-03-10 | 2002-04-16 | Magnesium Diagnostics, Inc. | Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| US20040171093A1 (en) * | 1999-03-10 | 2004-09-02 | Wells Ibert C. | Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| US8168592B2 (en) | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
| CN101374516A (zh) | 2006-01-27 | 2009-02-25 | 弗·哈夫曼-拉罗切有限公司 | 取代的咪唑啉的2-咪唑衍生物的用途 |
Family Cites Families (124)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL142416B (nl) * | 1969-04-30 | 1974-06-17 | Univ Osaka | Werkwijze voor het bereiden van 6-amino-acylaminopenicillanzuren, alsmede werkwijze voor de bereiding van farmaceutische preparaten. |
| US4097472A (en) | 1974-11-08 | 1978-06-27 | Mitsubishi Chemical Industries Limited | N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
| US4073913A (en) | 1974-11-08 | 1978-02-14 | Mitsubishi Chemical Industries Limited | N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| FR2166316A1 (en) * | 1972-01-07 | 1973-08-17 | Toyama Chemical Co Ltd | 7-acylcephalosporins - prepd via a silylated inter |
| IL42124A (en) | 1972-05-02 | 1977-02-28 | Kabi Ab | Substrate for the determination of proteolytic enzymes |
| US3894995A (en) | 1972-12-26 | 1975-07-15 | Hoechst Ag | Transparent polyamides from an isomeric mixture of norbornanes |
| US3885136A (en) * | 1974-02-25 | 1975-05-20 | Gulf & Western Industries | Reset timer/counter unit |
| US4201863A (en) | 1974-11-08 | 1980-05-06 | Mitsubishi Chemical Industries, Limited | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4144244A (en) | 1977-12-27 | 1979-03-13 | Ciba-Geigy Corporation | Perfluoroalkyl-iodo norbornane dicarboxylic acids and derivatives thereof |
| US4304771A (en) | 1979-07-13 | 1981-12-08 | Usv Pharmaceutical Corporation | Antihypertensive amides |
| US4352751A (en) | 1979-09-10 | 1982-10-05 | Analytical Radiation Corporation | Species-linked diamine triacetic acids and their chelates |
| US4331570A (en) | 1980-07-17 | 1982-05-25 | International Flavors & Fragrances Inc. | Carboamidoalkyl norbornanes and organoleptic use in perfumes |
| US4532342A (en) | 1981-02-20 | 1985-07-30 | Warner-Lambert Company | N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
| AU564576B2 (en) * | 1981-09-24 | 1987-08-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Purine derivatives |
| US4609661A (en) * | 1982-08-09 | 1986-09-02 | Syntex (U.S.A.) Inc. | Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents |
| DE3401949A1 (de) | 1984-01-20 | 1985-08-01 | Bayer Ag, 5090 Leverkusen | Norbornan- und norbornencarbonsaeureamide, verfahren zu deren herstellung sowie die verwendung von norbornan- und norbornencarbonsaeureamiden als arzneimittel |
| US4761481A (en) | 1985-03-18 | 1988-08-02 | Baxter Travenol Laboratories, Inc. | Substituted pyridine derivatives |
| DE8517666U1 (de) * | 1985-06-18 | 1985-08-14 | Heinrich Baumgarten KG, Spezialfabrik für Beschlagteile, 5908 Neunkirchen | Geschirrgriff für die Befestigung an Bolzen |
| US4705897A (en) | 1986-05-05 | 1987-11-10 | Texaco Inc. | Process for producing bicyclic diamines |
| US4772607A (en) | 1986-05-20 | 1988-09-20 | Warner-Lambert Company | Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
| GB8613431D0 (en) | 1986-06-03 | 1986-07-09 | Medical Res Council | Human tachykinins |
| IL83966A (en) | 1986-09-26 | 1992-03-29 | Schering Ag | Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them |
| CH676988A5 (de) * | 1987-01-21 | 1991-03-28 | Sandoz Ag | |
| US4792555A (en) | 1987-03-20 | 1988-12-20 | American Home Products Corporation | Phospholipase A2 inhibitors |
| US5128346A (en) | 1987-09-21 | 1992-07-07 | Abbott Laboratories | Derivatives of D-glutamic acid and D-aspartic acid |
| DE3804793A1 (de) | 1988-02-16 | 1989-08-24 | Hoechst Ag | Renin-hemmende aminosaeurederivate |
| US5256645A (en) | 1988-03-04 | 1993-10-26 | Hoffmann-La Roche Inc. | Amino acid derivatives |
| CA1328333C (en) | 1988-03-04 | 1994-04-05 | Quirico Branca | Amino acid derivatives |
| CA1330613C (en) | 1988-05-06 | 1994-07-05 | Masanori Kawamura | Amino acid derivatives |
| US5177089A (en) * | 1988-06-01 | 1993-01-05 | Eisai Co., Ltd. | Butenoic or propenoic acid derivative |
| CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
| JPH0225417A (ja) * | 1988-07-12 | 1990-01-26 | Asahi Chem Ind Co Ltd | 抗潰瘍剤 |
| FR2640970A1 (en) * | 1988-12-28 | 1990-06-29 | Pf Medicament | "Z"-1-Phenyl-2-(aminomethyl)cyclopropanecarboxamide derivatives and their therapeutic application |
| US5049548A (en) * | 1989-03-03 | 1991-09-17 | Merck & Co., Inc. | Renin-inhibitory di-, tri-, and tetrapeptides |
| US5616562A (en) | 1990-04-27 | 1997-04-01 | Murphy; Christopher J. | Methods and compositions using substance P to promote wound healing |
| IE920175A1 (en) | 1991-02-11 | 1992-08-12 | Zeneca Ltd | Nitrogen heterocycles |
| FR2676734B1 (fr) | 1991-05-23 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| US6011068A (en) * | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| EP0532466A3 (en) * | 1991-09-12 | 1993-06-16 | Ciba-Geigy Ag | Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
| US5527790A (en) * | 1991-09-30 | 1996-06-18 | The University Of British Columbia | Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar |
| JP3122520B2 (ja) | 1992-03-13 | 2001-01-09 | 生化学工業株式会社 | ２−アミノピリジン誘導体、その製造方法及び蛍光標識剤 |
| JP2578044B2 (ja) | 1992-03-14 | 1997-02-05 | 呉羽化学工業株式会社 | フェニルアラニン−グリシン誘導体、その製造方法、及びその誘導体を含有する抗腫瘍剤 |
| US5506227A (en) | 1992-04-13 | 1996-04-09 | Merck Frosst Canada, Inc. | Pyridine-substituted benzyl alcohols as leukotriene antagonists |
| EP0655055B1 (de) | 1992-08-13 | 2000-11-29 | Warner-Lambert Company | Tachykinin antagonistes |
| US5641783A (en) | 1993-11-12 | 1997-06-24 | Cell Therapeutics, Inc. | Substituted amino alcohol compounds |
| AU680870B2 (en) | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| JP3548205B2 (ja) * | 1993-10-29 | 2004-07-28 | キヤノン株式会社 | 画像処理方法およびその装置 |
| US6403577B1 (en) | 1993-11-17 | 2002-06-11 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| CA2109684C (en) * | 1993-11-22 | 2002-03-19 | Peter A. Pubben | Faucet control device |
| US5492927A (en) | 1993-12-21 | 1996-02-20 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists to treat allergy |
| ITFI940009A1 (it) | 1994-01-19 | 1995-07-19 | Menarini Farma Ind | Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono. |
| US5646155A (en) | 1994-05-12 | 1997-07-08 | University Of Massachusetts Medical Center | Drugs to prevent recurrent herpes virus infections |
| JPH10501228A (ja) | 1994-06-06 | 1998-02-03 | ワーナー−ランバート・コンパニー | タキキニン（ｎｋ▲下１▼）受容体アンタゴニスト |
| US5491140A (en) | 1994-06-30 | 1996-02-13 | Eli Lilly And Company | Naphthyl tachykinin receptor antagonists to treat physiological conditions |
| TW307746B (de) * | 1994-10-14 | 1997-06-11 | Sumitomo Chemical Co | |
| DE69533174T2 (de) | 1994-10-27 | 2004-11-18 | Fujisawa Pharmaceutical Co., Ltd. | Pyridopyrimidinone, chinoline und anellierte n-heterozyklen als bradykinin-antagonisten |
| US5607947A (en) | 1995-02-21 | 1997-03-04 | Eli Lilly And Company | Pyrrolidinyl tachykinin receptor antagonists |
| US5563133A (en) | 1995-02-21 | 1996-10-08 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| US5565568A (en) | 1995-04-06 | 1996-10-15 | Eli Lilly And Company | 2-acylaminopropanamides as tachykinin receptor antagonists |
| NZ320963A (en) | 1995-09-29 | 1999-08-30 | Lilly Co Eli | Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| WO1997016188A1 (en) * | 1995-10-30 | 1997-05-09 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
| CA2191924A1 (en) * | 1995-12-05 | 1997-06-06 | Kevin Felsenstein | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production |
| EP1997806A1 (de) | 1996-04-23 | 2008-12-03 | Targacept, Inc. | Pharmazeutische Zusammensetzungen zur Vorbeugung und Behandlung von Erkrankungen des zentralen Nervensystems |
| DE19629816A1 (de) | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| US5703173A (en) * | 1996-08-16 | 1997-12-30 | Integument Technologies, Inc. | Transition metallohalopolymers |
| GB9617305D0 (en) | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
| CN1169795C (zh) | 1996-10-01 | 2004-10-06 | 协和发酵工业株式会社 | 环胺取代的含氮杂环化合物及其组合物 |
| TR199901063T2 (xx) | 1996-11-14 | 1999-08-23 | Pfizer Inc. | �kame edilmi� piridinler i�in i�lem. |
| JPH10177774A (ja) | 1996-12-16 | 1998-06-30 | Fujitsu Ltd | ディスク装置及び携帯型電子装置 |
| JP2001506265A (ja) * | 1996-12-17 | 2001-05-15 | ワーナー−ランバート・コンパニー | タンパク質ファルネシルトランスフェラーゼのシクロアルキル阻害剤 |
| US6559144B2 (en) | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
| US6482836B1 (en) | 1997-04-22 | 2002-11-19 | Charles Huang | CRF antagonistic quino- and quinazolines |
| US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| KR20010014030A (ko) | 1997-06-19 | 2001-02-26 | 더글라스이.리디치 | 퀴놀린-인돌 항균제, 이들의 용도 및 조성물 |
| US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
| ES2352739T3 (es) * | 1997-11-21 | 2011-02-22 | Purdue Neuroscience Company | 2-aminoacetamidas sustituidas y el uso de las mismas. |
| US6174901B1 (en) | 1998-12-18 | 2001-01-16 | Amgen Inc. | Substituted pyridine and pyridazine compounds and methods of use |
| US6011066A (en) * | 1998-02-02 | 2000-01-04 | Veterans General Hospital-Taipei | Method for treating septic shock |
| US6133455A (en) * | 1998-02-09 | 2000-10-17 | American Cyanamid Company | Process for the preparation of 2-aryl-5(perfluoro-alkyl) pyrrole compounds from N-(arylmethylene)-1-chloro-1-(perfluoroalkyl) methylamine compounds |
| US6689754B1 (en) | 1998-04-10 | 2004-02-10 | G. D. Searle & Co. | Heterocyclic glycyl β-alanine derivatives |
| WO1999058505A2 (en) * | 1998-05-12 | 1999-11-18 | Warner-Lambert Company | Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| MY125037A (en) | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
| AU4956699A (en) | 1998-06-19 | 2000-01-05 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6090942A (en) | 1998-10-15 | 2000-07-18 | Pfizer Inc. | Process and intermediates for a β3 -adrenergic receptor agonist |
| TWI243192B (en) * | 1998-12-31 | 2005-11-11 | Ciba Sc Holding Ag | Phthalimidyl azo pigments, method for producing same and utilization thereof |
| WO2000051998A1 (en) | 1999-03-02 | 2000-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cathepsin s |
| AT407993B (de) * | 1999-03-03 | 2001-07-25 | Voest Alpine Ind Anlagen | Verfahren zur optimierung von auslegung und betrieb eines reduktionsverfahrens |
| US6372440B2 (en) | 1999-03-10 | 2002-04-16 | Magnesium Diagnostics, Inc. | Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| US6750348B1 (en) | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| AU4180900A (en) | 1999-04-02 | 2000-10-23 | Du Pont Pharmaceuticals Company | Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase |
| US6380210B1 (en) * | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| SG82692A1 (en) * | 1999-04-07 | 2001-08-21 | Sumitomo Chemical Co | Method for purifying beta-phenylethyl alcohol |
| US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| US20020169101A1 (en) * | 1999-05-10 | 2002-11-14 | Gonzalez Maria Isabel | Treatment of sexual dysfunction |
| JP2001079018A (ja) * | 1999-09-14 | 2001-03-27 | Gc Corp | 歯科用自動切削加工装置 |
| US6369729B1 (en) * | 1999-10-08 | 2002-04-09 | Cirrus Logic, Inc. | Common mode shift in downstream integrators of high order delta sigma modulators |
| WO2001040192A1 (fr) * | 1999-12-03 | 2001-06-07 | Kyoto Pharmaceutical Industries, Ltd. | Nouveaux composes heterocycliques et sels de ces derniers, utilisations de ces composes en medecine |
| EP1237880B1 (de) | 1999-12-17 | 2008-01-23 | Novartis Vaccines and Diagnostics, Inc. | Pyrazin-basierte hemmer der glycogen-synthase-kinase 3 |
| US6328386B1 (en) * | 2000-01-11 | 2001-12-11 | Takata Seat Belts Inc. | Seat belt system |
| US6656958B2 (en) | 2000-02-02 | 2003-12-02 | Abbott Laboratories | Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| US6593340B1 (en) * | 2000-02-28 | 2003-07-15 | Cv Technologies, Inc. | Pharmaceutical compositions containing N-propargylphentermine and related analogs to treat neurodegeneration and/or depression |
| WO2001070734A2 (en) | 2000-03-17 | 2001-09-27 | Bristol-Myers Squibb Pharma Company | Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| WO2001085693A1 (fr) * | 2000-05-11 | 2001-11-15 | Banyu Pharmaceutical Co., Ltd. | Dérivés n-acyltétrahydroisoquinoline |
| US6539771B1 (en) * | 2000-05-12 | 2003-04-01 | Delphi Technologies, Inc. | Seat sensor calibration method and system |
| US20030087915A1 (en) | 2000-05-12 | 2003-05-08 | Dull Gary Maurice | Pharmaceutical compositions and methods for use |
| US6750346B2 (en) * | 2000-05-23 | 2004-06-15 | Carl Zeiss Jena Gmbh | Stable near-infrared (NIR) marker dyes based on benzopyrylium-polymethines |
| DE10028402A1 (de) | 2000-06-13 | 2001-12-20 | Merck Patent Gmbh | Pyridin-2-yl-aminoalkycarbonylglycyl-beta-alanin und Derivate |
| US20020173507A1 (en) | 2000-08-15 | 2002-11-21 | Vincent Santora | Urea compounds and methods of uses |
| US6583153B2 (en) | 2000-12-12 | 2003-06-24 | Ortho-Mcneil Pharmaceutical, Inc. | 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone |
| US6943250B2 (en) * | 2001-03-06 | 2005-09-13 | Fmc Corporation | Protected aminofunctionalized polymerization initiators and methods of making and using same |
| WO2002079163A1 (en) | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Aminopyridine derivatives as estrogen receptor modulators |
| US6911447B2 (en) | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
| JP2004536057A (ja) | 2001-05-11 | 2004-12-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | ｐ３８インヒビターとして使用する２，５−二置換ピリジン、ピリミジン、ピリダジンおよび１，２，４−トリアジンの誘導体 |
| PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
| JP2005508979A (ja) | 2001-10-29 | 2005-04-07 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | システインプロテアーゼの可逆性インヒビターとして有用な化合物 |
| US6635771B2 (en) * | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
| KR100447255B1 (ko) | 2001-12-31 | 2004-09-07 | 주식회사 하이닉스반도체 | 입자 함침층 조성물 및 이를 이용한 연마 패드 |
| WO2003070892A2 (en) | 2002-02-15 | 2003-08-28 | The Regents Of The University Of Michigan | Inhibitors of rgs proteins |
| US7235558B2 (en) | 2002-06-06 | 2007-06-26 | Sanofi-Aventis Deutschland Gmbh | Inhibitors of the GPIb—vWF interaction, their preparation and use |
| US6989392B2 (en) | 2002-06-18 | 2006-01-24 | Abbott Laboratories | 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| US20030139427A1 (en) | 2002-08-23 | 2003-07-24 | Osi Pharmaceuticals Inc. | Bicyclic pyrimidinyl derivatives and methods of use thereof |
| JP2006510661A (ja) | 2002-12-06 | 2006-03-30 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Ｐｉ３ｋの阻害剤としてのベンズオキサジン−３−オン類及びその誘導体 |
-
2000
- 2000-08-09 US US09/635,266 patent/US6455734B1/en not_active Expired - Fee Related
-
2001
- 2001-08-09 AT AT01961984T patent/ATE324881T1/de not_active IP Right Cessation
- 2001-08-09 WO PCT/US2001/024909 patent/WO2002011714A2/en active IP Right Grant
- 2001-08-09 DE DE60119385T patent/DE60119385D1/de not_active Expired - Lifetime
- 2001-08-09 NZ NZ523915A patent/NZ523915A/en unknown
- 2001-08-09 CA CA002418951A patent/CA2418951A1/en not_active Abandoned
- 2001-08-09 EP EP01961984A patent/EP1355638B1/de not_active Expired - Lifetime
- 2001-08-09 AU AU2001283203A patent/AU2001283203A1/en not_active Abandoned
- 2001-08-09 JP JP2002517051A patent/JP2004508299A/ja active Pending
-
2002
- 2002-08-29 US US10/230,133 patent/US6664420B2/en not_active Expired - Fee Related
-
2003
- 2003-10-28 US US10/695,536 patent/US6855826B2/en not_active Expired - Fee Related
-
2004
- 2004-12-21 US US11/018,690 patent/US7041829B2/en not_active Expired - Fee Related
-
2005
- 2005-12-02 US US11/292,460 patent/US7132537B2/en not_active Expired - Fee Related
-
2006
- 2006-08-29 US US11/512,024 patent/US7211667B2/en not_active Expired - Fee Related
-
2007
- 2007-03-28 US US11/729,101 patent/US7405311B2/en not_active Expired - Fee Related
-
2008
- 2008-06-24 US US12/214,943 patent/US7619097B2/en not_active Expired - Fee Related
-
2009
- 2009-10-16 US US12/589,064 patent/US7795450B2/en not_active Expired - Fee Related
-
2010
- 2010-07-23 US US12/842,642 patent/US7982048B2/en not_active Expired - Fee Related
-
2011
- 2011-06-08 US US13/156,026 patent/US8129545B2/en not_active Expired - Fee Related
-
2012
- 2012-02-08 US US13/369,027 patent/US20120142781A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7132537B2 (en) | 2006-11-07 |
| US20040110692A1 (en) | 2004-06-10 |
| JP2004508299A (ja) | 2004-03-18 |
| EP1355638B1 (de) | 2006-05-03 |
| US20070197659A1 (en) | 2007-08-23 |
| US7982048B2 (en) | 2011-07-19 |
| EP1355638A2 (de) | 2003-10-29 |
| WO2002011714A3 (en) | 2003-08-14 |
| DE60119385D1 (de) | 2006-06-08 |
| US6455734B1 (en) | 2002-09-24 |
| US8129545B2 (en) | 2012-03-06 |
| US20120142781A1 (en) | 2012-06-07 |
| US7211667B2 (en) | 2007-05-01 |
| US7405311B2 (en) | 2008-07-29 |
| US20030040625A1 (en) | 2003-02-27 |
| US20060069259A1 (en) | 2006-03-30 |
| NZ523915A (en) | 2005-05-27 |
| US6664420B2 (en) | 2003-12-16 |
| CA2418951A1 (en) | 2002-02-14 |
| US20110021633A1 (en) | 2011-01-27 |
| US6855826B2 (en) | 2005-02-15 |
| WO2002011714A2 (en) | 2002-02-14 |
| US7041829B2 (en) | 2006-05-09 |
| US20070010535A1 (en) | 2007-01-11 |
| US20110281923A1 (en) | 2011-11-17 |
| US20050096279A1 (en) | 2005-05-05 |
| US7619097B2 (en) | 2009-11-17 |
| US7795450B2 (en) | 2010-09-14 |
| US20090030080A1 (en) | 2009-01-29 |
| US20100048711A1 (en) | 2010-02-25 |
| AU2001283203A1 (en) | 2002-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200501798A1 (ru) | Новые пептиды, которые связываются с рецептором к эритропоэтину | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| EA200501801A1 (ru) | Новые пептиды, которые связываются с рецептором эритропоэтина | |
| ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
| EA200500782A1 (ru) | Лечение геморрагического шока | |
| DE69429527D1 (de) | Inhibitoren von beta-amyloid-protein-herstellung | |
| EA200401365A1 (ru) | Способы лечения илеуса | |
| EA200501710A1 (ru) | Замещённые карбоновые кислоты | |
| NO20010446L (no) | Substituert anilidforbindelser og metoder | |
| DE69434431D1 (de) | Methoden zur behandlung von muskelerkrankungen und muskelstörungen | |
| DE602004032522D1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
| EA200501607A1 (ru) | Замещённые фенилалкановые кислоты | |
| NO20062300L (no) | Fremgangsmater og reagenser for behandling av inflammatoriske forstyrelser | |
| EA199900669A1 (ru) | Промежуточные соединения для получения замещенных n-[аминоиминометил или аминометил)фенил]пропиламидов | |
| DE60140871D1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
| NO20052272L (no) | CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom | |
| MA27880A1 (fr) | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique | |
| DE60140707D1 (de) | GSK3-Polypeptide | |
| ATE324881T1 (de) | Antagonisten der defektiven magnesiumbindung als therapeutische mittel und methoden zur behandlung von abnormalen physiologischen zuständen | |
| ATE499933T1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| NO20030155D0 (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| DE60330857D1 (de) | 5-ht4 antagonisten zur behandlung von herzversagen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |